Explore more publications!
Technology Channel Dominica
Got News to Share?

Technology Channel Dominica: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Channel Dominica.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 22, 2025

Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction
September 22, 2025

Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction

Indeterminate GlobeNewswire
Aivista Quant Capital Launches Caelus AI and AQC Token Ecosystem, Ushering in a New Era of Intelligent Investing
September 22, 2025

Aivista Quant Capital Launches Caelus AI and AQC Token Ecosystem, Ushering in a New Era of Intelligent Investing

Indeterminate GlobeNewswire
IMUNON Presents IMNN-001 Phase 2 Translational Data in Advanced Ovarian Cancer Demonstrating 13-Month OS Extension via Tumor Micro-Environment Shift
September 22, 2025

IMUNON Presents IMNN-001 Phase 2 Translational Data in Advanced Ovarian Cancer Demonstrating 13-Month OS Extension via Tumor Micro-Environment Shift

Indeterminate GlobeNewswire
24/7 Market News: Kraig Labs Targets Eco Luxury Spider Silk Apparel Market
September 22, 2025

24/7 Market News: Kraig Labs Targets Eco Luxury Spider Silk Apparel Market

Indeterminate GlobeNewswire
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
September 22, 2025

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Indeterminate GlobeNewswire
Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research
September 22, 2025

Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research

Indeterminate GlobeNewswire
Cerevance to Present Phase 2 Data on Solengepras in Parkinson’s Disease at the 2025 International Congress of Parkinson's Disease and Movement Disorders
September 22, 2025

Cerevance to Present Phase 2 Data on Solengepras in Parkinson’s Disease at the 2025 International Congress of Parkinson's Disease and Movement Disorders

Indeterminate GlobeNewswire
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025
September 22, 2025

Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025

Indeterminate GlobeNewswire
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
September 22, 2025

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Indeterminate GlobeNewswire
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
September 22, 2025

electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards

Indeterminate GlobeNewswire
Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)
September 22, 2025

Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)

Indeterminate GlobeNewswire
ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study
September 22, 2025

ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study

Indeterminate GlobeNewswire
Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation
September 22, 2025

Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation

Indeterminate GlobeNewswire
BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure
September 22, 2025

BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure

Indeterminate GlobeNewswire
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting
September 22, 2025

Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting

Indeterminate GlobeNewswire
Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti
September 22, 2025

Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti

Indeterminate GlobeNewswire
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
September 22, 2025

MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)

Indeterminate GlobeNewswire
Voltus Ranked #1 Aggregator in GW Under Management and C&I Programs in Wood Mackenzie’s 2025 VPP Report
September 22, 2025

Voltus Ranked #1 Aggregator in GW Under Management and C&I Programs in Wood Mackenzie’s 2025 VPP Report

Indeterminate GlobeNewswire
Advent Technologies Delivers State-of-the-Art Portable Fuel Cell Systems under Contract with the U.S. Department of Defense
September 22, 2025

Advent Technologies Delivers State-of-the-Art Portable Fuel Cell Systems under Contract with the U.S. Department of Defense

Indeterminate GlobeNewswire
Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration
September 22, 2025

Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions